All In Biotech

Free tool

FAERS Monitor: Timoptic

The FDA Adverse Event Reporting System collects reports from patients, clinicians and manufacturers. Counts are unverified reports, not rates: they rise with how widely a drug is used, how long it has been sold and media attention, a report can name several drugs, and a report does not show the drug caused the event.

Last checked: Nov 20, 2026FDA FAERS (openFDA) last updated: Oct 28, 2026Methods & limitations

Reports naming NDA 018086 or its brand name (Timoptic, Timolol Maleate). Reports on generic versions are filed under their own applications.

Reports

9,481

Serious

4,819

51% of reports

Hospitalization

2,117

Death reported

575

Any cause; not necessarily from the drug

Most reported reactions

MedDRA preferred terms.

  • treatment failure1,009
  • drug ineffective668
  • eye pain503
  • fatigue502
  • eye irritation432
  • dizziness363
  • diarrhoea341
  • nausea337
  • vision blurred316
  • dyspnoea309
  • headache302
  • off label use298
  • intraocular pressure increased290
  • death280
  • fall278

Reports by year received

View as table
YearReports
2004250
2005287
2006250
2007239
2008218
2009213
2010290
2011278
2012385
2013166
2014205
2015337
2016384
2017423
2018435
2019505
20201,537
2021474
2022500
2023568
2024560
2025600
2026376

Disproportionality screen

Proportional reporting ratio (PRR): how much more often each reaction appears in this drug's reports than in the other 21,044,678 FAERS reports. Flagged when PRR is at least 2, chi-squared at least 4 and there are 3 or more reports (Evans criteria). A screening statistic only.

ReactionReportsPRR95% CI lowerChi-squared
intraocular pressure increasedSignal29051.545.913,990
treatment failureSignal1,00927.325.825,367
eye painSignal50319.918.38,977
eye irritationSignal43216.815.36,360
vision blurredSignal3165.14.61,046
fall2781.91.7110
dizziness3631.61.586
fatigue5021.41.367
dyspnoea3091.21.111
diarrhoea3411.21.19
drug ineffective6681.11.010
headache3021.11.01
nausea3370.90.91
off label use2980.80.724
death2800.70.631

A high PRR for a reaction that is also the condition being treated (for example "disease progression" for a cancer drug) is expected and is not a safety signal.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.